Exclusion Criteria:~* Participants with CDR GS â‰¥2 at predose baseline Clinical Dementia Rating (CDR)
administration~* Participants who fulfill diagnostic criteria for Mild Cognitive Impairment (MCI) or
dementia/mild or major neurocognitive disorder suspected to be due to any etiology other than AD (example,
Parkinson's disease, cerebrovascular disease, normal pressure hydrocephalus, head injury, drug or alcohol
abuse/dependence, anoxic brain injury, (Et cetera\[etc\])~* Geriatric Depression Scale (GDS) 30 score greater
than (>) 12~* Hachinski Ischemic Scale (HIS) >4~* Has received medications that affect the central nervous
system (CNS), except treatments for AD, for less than 2 months; that is, doses of chronic medications that
effect the CNS should be stable for at least 2 months before the start of screening. If a participant has
recently stopped a chronic medication that effects the CNS, he or she must have discontinued treatment at least
2 months before the start of screening. Chronic use of benzodiazepines is not permitted
